Mark Moran

MARK MORAN, MD, MBA is the CEO and founder of BioMedicines, Inc. Dr.
Moran earned undergraduate degrees in both Mathematics and Physics from
the University of Oklahoma. After four years of service as an
Engineering Officer in the U.S. Navy aboard a nuclear-powered submarine,
Dr. Moran attended the Washington University School of Medicine in St.
Louis where he earned his medical degree. Dr. Moran also holds an MBA
from the Kellogg Graduate School of Management at Northwestern
University. Dr. Moran was a member of the faculty in the Department of
Medicine of the Stanford University School of Medicine, first as
Assistant Professor and subsequently as Clinical Associate Professor of
Medicine. Dr. Moran joined Searle in Skokie, Illinois, as an Associate
Director, Director and then Senior Director of Clinical Research. Dr.
Moran then served as Vice President of Medical Affairs and Vice
President of Operations at Glycomed Incorporated (a glycotechnology
company purchased in 1995 by Ligand Pharmaceuticals, Inc.). Dr. Moran
was next appointed President and Chief Executive Officer of Ansan
Pharmaceuticals, Inc. (purchased in 1997 by Discovery Laboratories,
Inc.). Dr. Moran is also the Inventor of intellectual property for which
new patent applications in Chemotherapy, Chemoprevention, and Radiation
Oncology are now assigned to BioMedicines.